We found that knockdown of TRPV4 before MPTP treatment inhibited the MPTP-induced activation of procaspase-1 (Fig. 7A) and significantly reduced the high protein levels of IL-18, COX-2, and 5-LOX in the SN of PD mice (Fig. 7B–D). Here, IL18 is linked to Parkinson disease.